爱必信(上海)生物科技有限公司
欢迎联系我们! 服务热线: 021-38015121
 
 
产品展厅
BGJ398, 872511-34-7
  • 品牌:爱必信(absin)
  • 产地:中国
  • 货号:abs810629
  • cas:872511-34-7
  • 价格: ¥631/瓶
  • 发布日期: 2022-04-07
  • 更新日期: 2025-09-19
产品详请
产地 中国
品牌 爱必信(absin)
货号 abs810629
用途 见爱必信官网
英文名称 见爱必信官网
包装规格 5mg,5mg,5mg,5mg,10mg,10mg,10mg,10mg,50mg,50mg,50mg,50mg,100mg,100mg,100mg,100mg
纯度 >98%%
CAS编号 872511-34-7
是否进口

公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!

 

抑制剂描述:

产品名称:BGJ398

产品别名:见爱必信官网

英文别名:BGJ398

靶点:FGFR

CAS:872511-34-7

纯度:>98%

外观:见爱必信官网

保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.

描述:BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with IC50 of 0.9 nM/1.4 nM/1 nM, >40-fold selective for FGFR versus FGFR4 and VEGFR2, and little activity to Abl, Fyn, Kit, Lck, Lyn and Yes. Phase 2.

溶解性:DMSO : 12 mg/mL (21.41 mM; Need ultrasonic)

体外研究:

BGJ398 also prevents VEGFR2 with low potency. The IC50 of BGJ398 for inhibiting VEGFR2 is 0.18 μM. BGJ398 suppresses other kinases including ABL, FYN, KIT, LCK, LYN and YES with IC50 of 2.3 μM, 1.9 μM, 0.75 μM, 2.5 μM, 0.3 μM and 1.1 μM, respectively. At the cellular level, BGJ398 inhibits the proliferation of the FGFR1-, FGFR2-Q, and FGFR3-dependent BaF3 cells with IC50 of 2.9 μM, 2.0 μM and 2 μM, respectively. BGJ398 interferes with autophosphorylation on specific tyrosine residues including FGFR-WT, FGFR2-WT, FGFR3-K650E, FGFR3-S249C and FGFR4-WT with IC50 of 4.6 nM, 4.9 nM, 5 nM, 5 nM and 168 nM, respectively. BGJ398 suppresses proliferation of the cancer cells with wild-type (WT) FGFR3 overexpression such as RT112, RT4, SW780 and JMSU1 with IC50 of 5 nM, 30 nM, 32 nM and 15 nM, respectively.

体内研究:In this orthotopic xenograft bladder cancer model, BGJ398 induces tumor growth inhibition and stasis after oral administration for 12 consecutive days at the doses of 10 and 30 mg/kg, respectively. Interestingly, the animals that received BGJ398 exhibits either no body weight loss (10 mg/kg) or 10% body weight gain (30 mg/kg), a further indication of efficacy. RT112 tumor-bearing and female Rowett rats receive a single oral administration of the monophosphate salt of BGJ398 at the doses of 4.25 and 8.51 mg/kg. BGJ398 significantly decreases the levels of pFRS2 and pMAPK in a dose-dependent manner. BGJ398 inhibits significantly bFGF-stimulated angiogenesis in a dose-dependent manner. However, BGJ398 does not impair VEGF-induced blood vessel formation.

产品信息订购:

  产品货号   产品名称   规格 价格 大包装及货期
  abs810629   BGJ398   5mg   631.00   立即咨询
  abs810629   BGJ398   10mg   942.00   立即咨询
  abs810629   BGJ398   50mg   1814.00   立即咨询
  abs810629   BGJ398   100mg   2862.00   立即咨询

产品更多信息请进入爱必信网站咨询

联系方式
手机:18438616290